40 related articles for article (PubMed ID: 22739156)
1. Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells.
Wang Y; Dai H; Li H; Lv H; Wang T; Fu X; Han W
Clin Dev Immunol; 2011; 2011():621414. PubMed ID: 21455282
[TBL] [Abstract][Full Text] [Related]
2. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
Li Y; Sharma A; Hoffmann MJ; Skowasch D; Essler M; Weiher H; Schmidt-Wolf IGH
Front Immunol; 2024; 15():1268652. PubMed ID: 38558822
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced killer cells combined with dendritic cells inhibited liver cancer cells.
Li QY; Shi Y; Huang DH; Yang T; Wang JH; Yan GH; Wang HY; Tang XJ; Xiao CY; Zhang WJ; Zhang M; Wang L; Gong Y; Yang W; Wu XY; Xiang Y
Int J Clin Exp Med; 2015; 8(4):5601-10. PubMed ID: 26131143
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery.
Silecchia G; Guarino E; Sinibaldi-Vallebona P; Pierimarchi P; Restuccia A; Spaziani E; Bernard P; Tuthill C; Garaci E; Rasi G
Cancer Immunol Immunother; 1999 Jul; 48(4):172-8. PubMed ID: 10431686
[TBL] [Abstract][Full Text] [Related]
5. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery.
Sha L; Zhang H; Zhang X
Open Life Sci; 2024; 19(1):20220793. PubMed ID: 38623586
[TBL] [Abstract][Full Text] [Related]
6. Chymotrypsin with sialendoscopy-assisted surgery for the treatment of chronic obstructive parotitis.
Sun HJ; Xiao JQ; Qiao QH; Bao X; Wu CB; Zhou Q
Int J Oral Maxillofac Surg; 2017 Jul; 46(7):877-882. PubMed ID: 28279602
[TBL] [Abstract][Full Text] [Related]
7. Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial.
Emekçi Özay Ö; Özay AC; Çağlıyan E; Okyay RE; Gülekli B
Gynecol Endocrinol; 2017 Jul; 33(7):524-528. PubMed ID: 28277112
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer.
Lin M; Xu K; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L
Immunol Lett; 2017 Apr; 184():98-104. PubMed ID: 28274792
[TBL] [Abstract][Full Text] [Related]
9. Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy.
Kristensen AM; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Höllsberg P; Deleuran B; Hvid M
Cytokine; 2017 Aug; 96():1-7. PubMed ID: 28267648
[TBL] [Abstract][Full Text] [Related]
10. Randomized Crossover Trial of Amoxapine Versus Vitamin B12 for Retrograde Ejaculation.
Hu J; Nagao K; Tai T; Kobayashi H; Nakajima K
Int Braz J Urol; 2017; 43(3):496-504. PubMed ID: 28266821
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial.
Cao C; Luo A; Wu P; Weng D; Zheng H; Wang S
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1225-1230. PubMed ID: 28265816
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).
Schmeel LC; Schmeel FC; Coch C; Schmidt-Wolf IG
J Cancer Res Clin Oncol; 2015 May; 141(5):839-49. PubMed ID: 25381063
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies.
Schmeel FC; Schmeel LC; Gast SM; Schmidt-Wolf IG
Int J Mol Sci; 2014 Aug; 15(8):14632-48. PubMed ID: 25196601
[TBL] [Abstract][Full Text] [Related]
14. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia].
Cai LL; Yang Y; Yang B; Zhu HL; Lu XC; Zhang WY; Yu RL; Chi XH; Wang Y; Dai HR; Han WD; Fan H; Li SX; Liu Y; Ran HH; Lin J; Tuo S; Tuo CW; Zhang F; Cao JP; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):564-70. PubMed ID: 22739156
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of autologous cytokine induced killer cells combined with IL-2 for therapy of elderly patients with B-cell malignant lymphoma].
Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Fan H; Li SX; Liu Y; Dai HR; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1244-9. PubMed ID: 21129269
[TBL] [Abstract][Full Text] [Related]
16. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
Yang B; Lu XC; Yu RL; Chi XH; Liu Y; Wang Y; Dai HR; Zhu HL; Cai LL; Han WD
Hematol Oncol; 2012 Sep; 30(3):115-22. PubMed ID: 22972689
[TBL] [Abstract][Full Text] [Related]
17. [Application of immune function test to evaluate effect of cytokine-induced autologous killer cell infusion for elderly patients with hematological malignancies].
Cai LL; Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Liu Y; Dai HR; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1250-5. PubMed ID: 21129270
[TBL] [Abstract][Full Text] [Related]
18. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
19. CIK as therapeutic agents against tumors.
Introna M
J Autoimmun; 2017 Dec; 85():32-44. PubMed ID: 28679475
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
